Tissue engineering and regenerative medicine

Clinics in Plastic Surgery

Volumn 30, Issue 4, 2003, Pages 581-588

  Jenkins, D Denison ^a   Yang, George P ^a   Lorenz, H Peter ^a   Longaker, Michael T ^a   Sylvester, Karl G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NAKED DNA;

AUTOGRAFT; EMBRYO CELL; GENE ACTIVATION; GENETIC ENGINEERING; HISTORY OF MEDICINE; HUMAN; MEDICAL SPECIALIST; NONVIRAL GENE THERAPY; ORGAN TRANSPLANTATION; REGENERATION; REVIEW; SOMATIC CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; VIRAL GENE THERAPY;

EID: 0242267976     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-1298(03)00076-2     Document Type: Review

References (58)

1. Cavazzana-Calvo M, Hacein-Bey S, de Saint G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000;288:669-72.
2. th century. Plast Reconstr Surg 2001;107:1014-21.
3. Kenny P, Higgins T, Coleman N, et al. The Ilizarov method: a report of 45 procedures for correction of long bone deformities in the lower limb. J Bone Joint Surg Br 1998;80S:71-2.
4. Zehi K, Karray S, Fathallah M, et al. Ilizarov external fixator for the treatment of nonunion following long bone osteomyelitis in children. J Bone Joint Surg Br 2000;82(Suppl 2):115.
5. Gosain AK, Santoro TD, Havlik RJ, et al. Midface distraction following Le Fort III and monobloc osteotomies: problems and solutions. Plast Reconstr Surg 2002;109:1797-808.
6. Mofid MM, Manson PN, Robertson BC, et al. Craniofacial distraction osteogenesis: a review of 3278 cases. Plast Reconstr Surg 2001;108:1103-4.
7. st century. Plast Reconstr Surg 2000;105:2467-81.
8. Cannon B. New honors for Joseph E. Murray, M.D., and Radford C. Tanzer, M.D. Plast Reconstr Surg 1987;80:753-4.
9. Murray JE, Merrill JP, Harrison JH. Renal homotransplantations in identical twins. Surg Forum 1955;6:432-6.
10. Calne RY, Alexandrc GPJ, Murray JE. A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs. Ann N Y Acad Sci 1962;99:743-61.
11. Murray JE, Merrill JP, Harrison JH, et al. Prolonged survival of human kidney homografts by immunosuppressive therapy. N Engl J Med 1963;268:1315-23.
12. US DOE human genome program. Available at http:// www.science.doe.gov/ober/hug_top.html. Accessed January 2003.
13. Wilmut I, Schnieke AE, McWhir J, et al. Viable offspring derived from fetal and adult mammalian cells. Nature 1997;385:810-3.
14. Hua S, Ronghua L, Yuet WK. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci USA 2000;97:13801-6.
15. Wiethoff CM, Middaugh CR. Barriers to nonviral gene delivery. J Pharm Sci 2003;92:203-17.
16. Tepper OM, Mehrara BJ. Gene therapy in plastic surgery. Plast Reconstr Surg 2002;109:716-34.
17. Bonadio J. Genetic approaches to tissue repair. Ann N Y Acad Sci 2002;961:58-60.
18. Warren SM, Sylvester KG, Chen CM, et al. New directions in bioabsorbable technology. Orthopedics 2002;25:1201-10.
19. Bonadio J, Smiley E, Patil P, et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 1999;5:753-9.
20. Patil PV, Graziano GP, Bonadio J. Interbody fusion augmentation using localized gene delivery. Trans Orthop Res Soc 2000;25:360.
21. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for x-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-6.
22. Marshall E. Gene therapy: second child in French trial is found to have leukemia. Science 2003;299:320.
23. Check E. Second cancer case halts gene-therapy trials. Nature 2003;421:305.
24. Ciment J. Gene therapy experiments put on "clinical hold." BMJ 2000;320:336.
25. Sailaja G, HogenEsch H, North A, et al. Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response. Gene Ther 2002;9:1722-9.
26. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9.
27. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;2:211-28.
28. Weissman I. Stem cells: scientific, medical, and political issues. N Engl J Med 2002;346:1576-9.
29. Wagers AJ, Sherwood RI, Christensen JL, et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002;297:2256-9.
30. Brazelton TR, Rossi FM, Keshet GI, et al. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000;290:1775-9.
31. Blau HM. Stem-cell fusion: a twist of fate. Nature 2002;419:437.
32. Gepstein L. Derivation and potential applications of human embryonic stem cells. Circ Res 2002;91:866-76.
33. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-6.
34. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived human blastocysts. Science 1998;282:1145-7.
35. Weissman IL. Therapeutic cloning. N Engl J Med 2002;347:1619-22.
36. Macilwain C. Human cloning claim sparks fear of Senate backlash. Nature 2003;421:3.
37. Shin T, Kraemer D, Pryor J, et al. A cat cloned by nuclear transplantation. Nature 2002;415:859.
38. Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001;414:118-21.
39. Lagasse E, Shizuru JA, Uchida N, et al. Toward regenerative medicine. Immunity 2001;14:425-36.
40. Park KI, Ourednik J, Ourednik V, et al. Global gene and cell replacement strategies via stem cells. Gene Ther 2002;9:613-24.
41. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
42. Eiselt P, Kim BS, Chacko B, et al. Development of technologies aiding large-tissue engineering. Biotechnol Press 1998;14:134-40.
43. Kim WS, Vacanti CA, Upjohn J, et al. Bone deficit repair with tissue-engineered cartilage. Plast Reconstr Surg 1994;94:580-4.
44. Cao Y, Vacanti JP, Paige KT, et al. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg 1997;100:297-302.
45. Freed LE, Marquis JC, Nohria A, et al. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mat Res 1993;27:11-23.
46. Ishaug SL, Crane GM, Miller MJ, et al. Bone formation by three-dimensional stromal osteoblasts culture in biodegradable polymer scaffolds. J Biomed Mat Res 1997;36:17-28.
47. Noth U, Tuli R, Osyczka AM, et al. In vitro engineered cartilage constructs produced by press-coating biodegradable polymer with human mesenchymal stem cells. Tissue Eng 2002;8:131-44.
48. Whang K, Healy HE, Elenz DR, et al. Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng 1999;5:35-51.
49. Yang S, Leong K, Du Z, et al. The design of scaffolds for use in tissue engineering. Part II: rapid prototyping techniques. Tissue Eng 2002;9:1-11.
50. Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002;109:1291-302.
51. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889-95.
52. Ochi M, Uchio Y, Kawasaki K, et al. Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. J Bone Joint Surg Br 2002;84B:571-8.
53. Phillips TJ. Tissue-engineered skin: an alternative to spIit-thickness skin grafts? Arch Dermatol 1999;135:977-8.
54. Phillips TJ, Manzoor J, Rojas A, et al. The longevity of a bilayered skin substitute after application to venous ulcers. Arch Dermatol 2002;138:1079-81.
55. Bello YM, Falabella AF, Eaglstein WH. Tissue-engineered skin: current status in wound healing. Am J Clin Dermatol 2002;2:305-13.
56. Gath HJ, Hell B, Zarrinbal R, et al. Regeneration of intraoral defects after tumor resection with a bioengineered human dermal replacement (Dermagraft). Plast Reconstr Surg 2002;109:889-93.
57. Overturf K, Al-Dhalimy M, Tanguay R, et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of tyrosinaemia type 1. Nat Genet 1996;12:266-73.
58. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-34.